Search

Lxbio Pharmaceuticals is a Portuguese biotechnology company dedicated to developing innovative biopharmaceutical solutions, with a particular focus on phage therapy. Their mission is to revolutionize disease treatment and prevention, enhan

Lysando develops microbiome-friendly technologies to reduce bacterial threats and support the body's natural balance through safe, targeted protein innovations.

Prof. Dr. Rajani Malla, of the Central Department of Biotechnology, lists publications on bacteriophages, including therapeutic efficacy of bacteriophage therapy against carbapenem-resistant Klebsiella pneumoniae in a mouse model.

The Maresso Lab seeks to understand the molecular basis by which some of Earth's most deadly and infectious bacteria cause human disease, aiming to generate next-generation antimicrobials, vaccines and prophylactics.

Publisher of PHAGE: Therapy, Applications, and Research. The journal moved from Mary Ann Liebert, Inc. when Sage acquired Liebert (completed December 2024). Mary Ann Liebert, Inc. publishers Acquired by Sage; its journals moved to the Sage

Research, development, and manufacturing of bacteriophages. GMP certified producer. Ready to collaborate to introduce the bacteriophages to the world. Prague CZ

Our research seeks to apply phage and phage-encoded genes and genetic systems toward the generation of new process innovations with application to the design of novel therapeutics and optimized production/purification platforms. We are affi

The Meyer Lab at UC San Diego studies the ecology and evolution of life using microbial experimental systems, including evolution experiments on bacteriophage lambda and applying phage-bacterial coevolution to phage therapeutics.

Michael Baym, Associate Professor of Biomedical Informatics at Harvard Medical School, is a microbiologist and applied mathematician studying bacterial evolution and computational genomics. Lab members' bios include work on how phages, bact

Development and production of phage cocktails for food safety application.

MICREOS is a Swiss-based biotechnology company pioneering a new class of precision biologics to selectively eliminate disease-driving pathogens. Its engineered endolysin platform starts in atopic dermatitis, with endolysins designed to elim

Micreos is a platform biotech company focused on discovering and developing recombinant proteins and phage-based antimicrobial vectors to target AMR pathogens in infectious diseases, dermatology, and oncology.

The Microbial Active Genetics Lab is a lab at Amrita School of Biotechnology, opened in 2019 according to a university news item. Graduate student Nitasha Menon's bio says her research uses isolated bacteriophages against clinical multidrug

The Microbial Interaction Ecology group at the Helmholtz Centre for Environmental Research (UFZ) uses theory, lab experiments and field surveys to study bacteria, viruses (phage) and protists and their interactions. Its topics include phage

I am a lecturer at Microbiology Department, Faculty of Veterinary Medicine, Cairo University. I am really interested in phage biology and its applications for the treatment in veterinary field. My department teaches basic Microbiological co

NPO Microgen's product page lists bacteriophage preparations, including Klebsiphage®, which causes specific lysis of Klebsiella pneumoniae, Klebsiella ozaenae and Klebsiella rhinoscleromatis.

MicroMol GmbH, later TentaMedix GmbH Karlsruhe DE

Mathias Middelboe, Professor in the Department of Biology at the University of Copenhagen, focuses on marine viral ecology and virus-host interactions. Part of his work explores using viruses, including phages, in aquaculture disease contro

Mikroliz Therapeutic Bacteriophage Bank (MTBB) is established in Turkey which currently has over 800 phages against mainly the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas

Sylvain Moineau's research team at Université Laval in Québec specializes in the characterization of bacteriophages, combining genomics, transcriptomics, proteomics and structural biology to understand phage–bacteria interactions.